Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt (Q36222164)

12 August 2017

1 reference

title

Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. (English)

1 reference

12 August 2017

Neil Blumberg

1

1 reference

12 August 2017

1 August 2005

1 reference

12 August 2017

1 reference

12 August 2017

45

1 reference

12 August 2017

33S-39S; discussion 39S-40S

1 reference

12 August 2017

2 Suppl

1 reference

Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions.

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

The relationship of blood transfusion, tumor staging, and cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

Immunomodulation by blood transfusion: an evolving scientific and clinical challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

Blood transfusion and total joint replacement surgery: T helper 2 (TH2) cytokine secretion and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00529.X

10.1111/J.1537-2995.2005.00529.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16086785